- Beginners Guide (Training Resources)
- Core Facilities, Communities & Societies
- Flow Cytometry Instruments, Software & Upgrades
- Meetings & Conferences
- Online Resources
- Panel Design Resource
- Positions Available
- Reagents, Consumables & Services
- Science News
- Sponsors' Portals
Antibodypedia: Searchable database of antibodies
Antibodypedia is developed through collaboration between Antibodypedia AB and the Nature Publishing Group. It aims to provide the research community with information on the effectiveness of specific antibodies in specific applications — to help scientists select the right antibody for the right application.
Antibodypedia now catalogues more than 500,000 individual antibodies, which collectively detect 88% of the proteins encoded by the human genome and holds the results of nearly 145,000 experiments performed with these antibodies, as well as 32,000 links to publications related to their use.
The Antibodypedia database was originally developed within the 6th framework EU program Proteome Binders and the project is part of the Human Antibody Initiative.
Antibodypedia contains information about publicly available antibodies generated by academic or commercial providers and directed against human protein targets; we hope to extend coverage to a range of model organisms in the near future. The database is organized in a ‘gene-centric’ manner to provide users with an overview of all antibodies available against a particular target. All antibody pages link directly to the provider for ease of access and use of the database is free-of-charge.
We encourage commercial providers to submit information regarding their inventory of antibodies along with links to quality control data. Independent users can submit their own application-specific experimental data using standard validation criteria (supportive or non-supportive) developed with the assistance of an international advisory board recruited from academic research institutions. Users can also comment on specific antibodies without submitting validation data.
Antibodies can at any time be withdrawn from the database by the provider and all data (from provider and users) will in this case be removed.